• Contemporary ClinicContemporary Clinic
  • OTC GuideOTC Guide
  • Pharmacy Times
  • PTCEPTCE
  • Pharmacist Moms GroupPharmacist Moms Group
News
All News
FDA Updates
Press Releases
Media
All Videos
Digital Detail
Independent Corner
Insights
Interviews
MEDcast
Medical World News
Microsites
Peer Exchange
Perfect Consult
Podcasts
Practice Pearls
Sponsored Webcast
Student Voices
Webinars/Webcasts
Conferences
Conference Coverage
Conference Listing
Publications
Pharmacy Times
Pharmacy Practice in Focus: Oncology
Pharmacy Practice in Focus: Health Systems
Pharmacy Careers
All Publications
About the Publications
Author Submission
Submit to Pharmacy Practice in Focus: Oncology
Submit to Pharmacy Practice in Focus: Health Systems
Become a Peer Reviewer
Supplements & Featured Publications
Clinical
503B Compounding Pharmacy
ADHD
Allergy
Alzheimer Disease
Anxiety
Asthma
Atopic Dermatitis
Biosimilars
Bipolar Disorder
Brain Health
Breast Cancer
C. Difficile
COPD
COVID-19
Cardiovascular Health
Cervical Cancer
Cholangiocarcinoma
Cholesterol
Chronic Kidney Disease
Chronic Lymphocytic Leukemia
Classical Hematology
Colorectal Cancer
Continuous Glucose Monitoring
Cough and Cold
Depression
Dermatology
Diabetes
Digestive Health
Dry Eye Disease
Epilepsy
Eye Care
Flu
Future of Pharmacy
Gastrointestinal Cancer
Gastrointestinal Health
Gout
HER2 Breast Cancer
HIV
Heart Failure
Hematology
Hepatitis/MASH
Immunization
Immuno-oncology
Immunoglobulins
Infectious Disease
Lung Cancer
Lymphoma
Macular Degeneration
Mental Health
Migraine
Multiple Myeloma
Multiple Sclerosis
Myelofibrosis
Neurology
Neutropenia
Osteoporosis
Ovarian Cancer
Pain Management
Parkinson Disease
Pediatrics
Pharmacy Heroes
Pharmacy Management
Pneumococcal
PrEP
Prostate Cancer
Psoriasis
Psoriatic Arthritis
Psychedelics
Reimbursement
Reproductive Health
Respiratory Syncytial Virus
Rheumatoid Arthritis
Schizophrenia
Shingles
Skin Cancer
Sleep
Travel Vaccines
Veterinary Pharmacy
Vitamins and Supplements
Weight Management
Women's Health
Events
Upcoming Events
Upcoming Webinars
CE
Resources
Clinical Forum
Cou-Co
Educated Patient
Information for the Pharmacist
Interactive Tools
Partners
Sponsored
Whiteboards
Subscribe
logo
Spotlight
Community/RetailHospitalOncologyPharmacy TechnicianStudent
Clinical Role
Community/RetailHospitalOncologyPharmacy TechnicianSpecialty PharmacyStudent
Clinical
CoronavirusBrain HealthCardiovascular HealthDermatologyDiabetesFluHeart FailureHepatitis/MASHImmunizationMigrainePneumococcalVitamins and Supplements
Supplement Spotlight
October 2023 Pharmacy Technician Edition
All News
FDA Updates
Press Releases
All Videos
Digital Detail
Independent Corner
Insights
Interviews
MEDcast
Medical World News
Microsites
Peer Exchange
Perfect Consult
Podcasts
Practice Pearls
Sponsored Webcast
Student Voices
Webinars/Webcasts
Conference Coverage
Conference Listing
Pharmacy Times
Pharmacy Practice in Focus: Oncology
Pharmacy Practice in Focus: Health Systems
Pharmacy Careers
All Publications
About the Publications
Author Submission
Submit to Pharmacy Practice in Focus: Oncology
Submit to Pharmacy Practice in Focus: Health Systems
Become a Peer Reviewer
Supplements & Featured Publications
503B Compounding Pharmacy
ADHD
Allergy
Alzheimer Disease
Anxiety
Asthma
Atopic Dermatitis
Biosimilars
Bipolar Disorder
Brain Health
Breast Cancer
C. Difficile
COPD
COVID-19
Cardiovascular Health
Cervical Cancer
Cholangiocarcinoma
Cholesterol
Chronic Kidney Disease
Chronic Lymphocytic Leukemia
Classical Hematology
Colorectal Cancer
Continuous Glucose Monitoring
Cough and Cold
Depression
Dermatology
Diabetes
Digestive Health
Dry Eye Disease
Epilepsy
Eye Care
Flu
Future of Pharmacy
Gastrointestinal Cancer
Gastrointestinal Health
Gout
HER2 Breast Cancer
HIV
Heart Failure
Hematology
Hepatitis/MASH
Immunization
Immuno-oncology
Immunoglobulins
Infectious Disease
Lung Cancer
Lymphoma
Macular Degeneration
Mental Health
Migraine
Multiple Myeloma
Multiple Sclerosis
Myelofibrosis
Neurology
Neutropenia
Osteoporosis
Ovarian Cancer
Pain Management
Parkinson Disease
Pediatrics
Pharmacy Heroes
Pharmacy Management
Pneumococcal
PrEP
Prostate Cancer
Psoriasis
Psoriatic Arthritis
Psychedelics
Reimbursement
Reproductive Health
Respiratory Syncytial Virus
Rheumatoid Arthritis
Schizophrenia
Shingles
Skin Cancer
Sleep
Travel Vaccines
Veterinary Pharmacy
Vitamins and Supplements
Weight Management
Women's Health
Upcoming Events
Upcoming Webinars
CE
Clinical Forum
Cou-Co
Educated Patient
Information for the Pharmacist
Interactive Tools
Partners
Sponsored
Whiteboards
Subscribe
Advertisement

CLINICAL ROLE -

Community/Retail
| Hospital
| Oncology
| Pharmacy Technician
| Student

Article

January 13, 2017

Top 10 Healthcare Trends for 2017

Author(s):

Laurie Toich, Assistant Editor

Top trends will include changing policies, pursuing value, and improving access to care.

With the Affordable Care Act (ACA) potentially seeing its final days in 2017, healthcare policy is likely going to undergo significant changes in the year ahead. Revamping the healthcare system by repealing the ACA is the major stated goal of Republican lawmakers this year, which, if last year’s health trends continue, will not be an easy task.

According to Avalere Health’s 2017 Healthcare Industry Outlook, 2017 will be a year of policy changes, pursuing value, and accessing care.

These are the 10 trends to look out for in 2017, according to Avalere:

1. How Will the Election Affect Insurance?

Besides the ACA repeal, experts at Avalere are predicting that Medicare and Medicaid programs will be altered to drive down spending, introduce more private plans, and give states more control.

2. Workers Will be Responsible for More Employer-Sponsored Insurance CostsSince many employer plans are modeling their options after ACA plans, patients may find themselves in a plan with narrow networks, high out-of-pocket costs, and restricted formularies, according to Avalere. This may result in patients forgoing necessary medical care.

3. Drug Pricing Will Change

In 2017, lawmakers may implement policies that encourage value-based contracts, FDA reform, and increase transparency in drug pricing to prevent pharmaceutical companies from inflating drug prices without cause.

4. Will be Biosimilars Hit Formularies?

As more biosimilars are receiving FDA approval, payers will have to decide whether they will include these drugs in their formularies instead of biologics. Payers may also choose to rely on the competition between biosimilars and reference products to reduce costs even further, according to Avalere.

5. Outcomes-Based Contracts Change Drug Purchasing

This type of contract could be the key to reducing drug prices, since payment is contingent on the quality of the product, which could deter manufacturers from selling a drug that is less effective than a competing drug.

6. Value-Based Payment

Private and public payers will continue to adopt value-based payment models. Currently, the Center for Medicare and Medicaid Innovation is testing these options in 46 programs to demonstrate their value, according to the report.

7. Quality Measures

Standardization of quality measures allows for a streamlined process of data aggregation, and can allow for easy comparison between drugs, health plans, and healthcare facilities. Using the Medicare Quality Payment Program to increase the creation of quality measures would benefit the industry.

8. Focus on Post-Acute Care In 2017, a focus on new care models will result in improving the care a patient receives after they are discharged from a hospital stay. This will lead to a reduction in unnecessary readmission, lower costs, and improve patient outcomes.

9. Improving Value Frameworks

Value frameworks are currently underused, and have demonstrated a limited beneficial impact thus far. Improvements in transparency measures, and the use of patient experience in models would likely generate a better uptake in 2017.

10. Digital Health

Web- and application-based programs have allowed patients to better manage their diseases, while increasing remote healthcare services. According to the report, even more of these programs will be actualized in 2017.

Related Videos
Image credit: Photo18@desing | stock.dobe.com
fda on paper texture - Image credit: Araki Illustrations | stock.adobe.com
Image Credit: © utah51 - stock.adobe.com
Related Content
Advertisement
Cimerli Offers a New, Interchangeable Biosimilar for Ocular Conditions
May 1st 2025

Cimerli Offers a New, Interchangeable Biosimilar for Ocular Conditions

Melissa Garcia, PharmD Candidate Saro Arakelians, PharmD
Pharmacy Focus: AMCP Nexus 2023 - Recap on Biosimilar Updates
November 3rd 2023

Pharmacy Focus: AMCP Nexus 2023 - Recap on Biosimilar Updates

Selective focus close up man hand with dry itchy skin conditions peeling texture detail. Old man hand with flaking and cracked allergic dermatitis on his skin - Image credit: CandyRetriever | stock.adobe.com
April 15th 2025

FDA Grants Interchangeable Designation to Yuflyma for Humira

Kennedy Ferruggia, Assistant Editor
Pharmacist Moms: Coffee With Suzy - Episode 19
June 24th 2022

Pharmacist Moms: Coffee With Suzy - Episode 19

biosimilar word or concept represented by wooden letter tiles on a wooden table with glasses and a book - Image  credit: lexiconimages | stock.adobe.com
April 3rd 2025

Organon Expands Portfolio With Biosimilar Tocilizumab-bavi for Arthritis and COVID-19

Kennedy Ferruggia, Assistant Editor
fda on paper texture - Image credit: Araki Illustrations | stock.adobe.com
March 27th 2025

Denosumab-bnht Biosimilar Receives FDA Approval

Kennedy Ferruggia, Assistant Editor
Related Content
Advertisement
Cimerli Offers a New, Interchangeable Biosimilar for Ocular Conditions
May 1st 2025

Cimerli Offers a New, Interchangeable Biosimilar for Ocular Conditions

Melissa Garcia, PharmD Candidate Saro Arakelians, PharmD
Pharmacy Focus: AMCP Nexus 2023 - Recap on Biosimilar Updates
November 3rd 2023

Pharmacy Focus: AMCP Nexus 2023 - Recap on Biosimilar Updates

Selective focus close up man hand with dry itchy skin conditions peeling texture detail. Old man hand with flaking and cracked allergic dermatitis on his skin - Image credit: CandyRetriever | stock.adobe.com
April 15th 2025

FDA Grants Interchangeable Designation to Yuflyma for Humira

Kennedy Ferruggia, Assistant Editor
Pharmacist Moms: Coffee With Suzy - Episode 19
June 24th 2022

Pharmacist Moms: Coffee With Suzy - Episode 19

biosimilar word or concept represented by wooden letter tiles on a wooden table with glasses and a book - Image  credit: lexiconimages | stock.adobe.com
April 3rd 2025

Organon Expands Portfolio With Biosimilar Tocilizumab-bavi for Arthritis and COVID-19

Kennedy Ferruggia, Assistant Editor
fda on paper texture - Image credit: Araki Illustrations | stock.adobe.com
March 27th 2025

Denosumab-bnht Biosimilar Receives FDA Approval

Kennedy Ferruggia, Assistant Editor
Consent Preferences
About Us
Clinical Forums
Advertise
Contact Us
Editorial Staff
Privacy Policy
Terms & Conditions
Do Not Sell My Information
Contact Info

2 Commerce Drive
Cranbury, NJ 08512

609-716-7777

© 2025 MJH Life Sciences

All rights reserved.